Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
19 results
- D3.519 - Post-COVID-19 Reshaping of Molecular IgE Sensitization Profiles to Seasonal and Indoor Allergens
- D3.520 - Post-COVID Olfactory and Taste Dysfunction in Students at a South African Medical School
D3.521 - Dermatologic adverse effects of COVID-19 vaccination
- D3.522 - Post-Vaccination SARS-CoV-2 Infections: Evidence, Severity, and Outcomes
D3.523 - Early childhood: a risk predictor for post-COVID-19 pulmonary sequelae in children
- D3.524 - Clinical use of procalcitonin and IL-6 in diagnosis of bacterial superinfection in COVID-19
- D3.525 - One- year hospital readmission after pediatric COVID- 19 hospitalization: a single- center cohort study
- D3.526 - Baseline demographic characteristics and early-life exposures in infants born during and after the COVID-19 pandemic: A comparison of the CORAL and FLORAL birth cohorts
- D3.527 - Multisystem Inflammatory Syndrome in Children (MIS-C) as a Condition Resulting from Immune Dysregulation: What has Coronavirus Infection Taught Us? (Case Study)
- D3.540 - Sources of IL-13 in Acute Versus Chronic Models of Eosinophilic Esophagitis
- D3.538 - Aeroallergen sensitisation as a risk factor for paediatric eosinophilic esophagitis
- D3.539 - Evaluation of Treatment Selection and Response in Patients with Eosinophilic Esophagitis Based on Clinical Findings and Allergy Testing
- D3.541 - Who takes the patient with eosinophilic esophagitis (EoE) and acute laryngeal edema?
- D3.542 - Prevalence of sensitization to panallergens and IgG4 profiles against specific foods in patients with allergic-phenotype eosinophilic esophagitis
- D3.545 - Natural Killer and Dendritic Cells Leverage Synergistic Interactions to Enhance Treatment of Non-Small Cell Lung Cancer
- D3.544 - Allergic biomarkers and clinical outcomes in lung cancer patients treated with immune checkpoint inhibitors: a pilot study
- D3.546 - AllergoOncology: Basophil number and subpopulation proportions may offer potential as predictive biomarkers in non-small cell lung cancer
- D3.547 - Clinical Outcomes and Safety of Drug Desensitization in Chemotherapy-Induced Hypersensitivity
- D3.548 - Refractory and persistent pruritus in an atopic patient: A red flag for underlying malignancy?
Download the app
The congress at your fingertips
Available on
Download